Drug Shortage Report for NORDITROPIN NORDIFLEX

Last updated on 2023-09-01 History
Report ID 178312
Drug Identification Number 02334860
Brand name NORDITROPIN NORDIFLEX
Common or Proper name NORDITROPIN NORDIFLEX
Company Name NOVO NORDISK CANADA INC
Market Status MARKETED
Active Ingredient(s) SOMATROPIN
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size EA
ATC code H01AC
ATC description ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-02-01
Actual start date 2023-02-01
Estimated end date Unknown
Actual end date 2023-08-31
Shortage status Resolved
Updated date 2023-09-01
Company comments Norditropin® NordiFlex® 15 mg will continue to be available to Canadian patients to ensure all patients currently taking Norditropin® can remain on treatment.
Health Canada comments
Tier 3 Status No
Contact Address 101-2476 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 6M1
Company contact information 1 800 465 4334

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-12-14 English Compare
v2 2022-12-14 English Compare
v3 2022-12-14 French Compare
v4 2022-12-14 English Compare
v5 2022-12-14 French Compare
v6 2022-12-14 French Compare
v7 2023-02-02 English Compare
v8 2023-03-17 English Compare
v9 2023-03-17 French Compare
v10 2023-06-26 English Compare
v11 2023-06-26 French Compare
v12 2023-06-26 English Compare
v13 2023-06-26 French Compare
v14 2023-08-31 English Compare
v15 2023-08-31 French Compare
v16 2023-09-01 English Compare

Showing 1 to 16 of 16